Market News & Trends
FDA Launches Initiative to Rethink Rare Disease Drug Development Framework
The U.S. Food and Drug Administration (FDA) is launching a new initiative aimed at addressing longstanding challenges in rare disease drug development, including the difficulty…
Senopsys Marks 20 Years of Sensory Science in Pharmaceutical Formulation Development
As pharmaceutical developers place greater emphasis on patient-centric drug design, Senopsys is marking 20 years of helping biopharmaceutical companies address one of formulation development’s practical…
Biomapas Acquires Pinnaxis to Expand Drug Safety Technology Capabilities
Biomapas has acquired Pinnaxis, a pharmacovigilance technology and consulting company based in Noida, India, in a move aimed at expanding its drug safety technology capabilities,…
Thermo Fisher Collaboration Identifies More Than 2,500 New Genetic-Protein Associations
Thermo Fisher Scientific, Precision Health Research, Singapore (PRECISE) and Nanyang Technological University Singapore (NTU Singapore) have identified more than 2,500 previously unreported genetic-protein associations through…
Lonza Extends Accelerated DNA-to-IND Pathway to Complex Biologics
Lonza is expanding its accelerated DNA-to-Investigational New Drug (IND) development offering beyond monoclonal antibodies (mAbs), adding support for more complex biologic formats as drug developers…
Lonza Adds Qurient's CDK7 Inhibitors to Dual-Payload ADC Technology Portfolio
Lonza is expanding its antibody-drug conjugate (ADC) technology portfolio through an exclusive licensing agreement with South Korean biopharmaceutical company Qurient, gaining access to Qurient's cyclin-dependent…
Lonza, Onava Partner to Generate Experimental Data for AI-Driven Biologics Discovery
Lonza and Onava have entered into a research collaboration aimed at strengthening the experimental validation of AI-designed biologics, using Lonza's GS Gene Expression System platform…
Carterra, AstraZeneca Collaborate on Hardware and Software for AI-Driven Drug Discovery
Carterra is working with AstraZeneca on a research collaboration focused on developing the laboratory hardware and software needed to support more connected, AI-driven approaches to…
CPHI Pharma Awards 2026 Spotlight Innovation Across Pharma Industry
The winners of the 2026 CPHI Pharma Awards have been announced in Milan, with companies, projects and industry leaders recognized across 15 categories covering drug…
Thermo Fisher Expands Drug Development and Manufacturing Offerings at CPHI Milan 2026
Thermo Fisher Scientific is using CPHI Milan 2026 to highlight a broader set of drug development, manufacturing, clinical supply, and digital capabilities aimed at helping…
Terumo Launches K-Pack Embrace Safety Needle for Automated Drug Co-packing
Terumo Corp. has launched a new active safety needle designed to support automated processes used to combine injection needles with drug products and syringes. The…
PacBio, TychoBio Join Forces to Build AI Models for Rare Disease RNA Therapies
PacBio and AI drug discovery company TychoBio are collaborating on a large-scale sequencing effort aimed at improving the design of RNA-based treatments for rare diseases.…
Biopharma Industry Launches Consortium to Build Digital Standards for CMC
A new industry consortium launched today aims to tackle one of biopharma's persistent digitalization challenges: bringing chemistry, manufacturing and controls (CMC) processes into a standardized,…
CPHI Broadens European Strategy With New Spain Event and Specialist Frankfurt Zones
CPHI is expanding its European event portfolio in 2027, adding a new country-focused pharmaceutical exhibition in Spain while expanding its flagship Frankfurt event into several…
Upperton Unveils New Brand as it Expands Specialist CDMO Offering
Nottingham, UK-based pharmaceutical development and manufacturing company Upperton Pharma Solutions has introduced a new brand identity as it enters a new stage of growth, positioning…
Ofichem to Acquire Kinentia Biosciences, Expanding US Drug Substance Footprint
Ofichem is set to establish its first operational presence in the US drug substance market through an agreement to acquire New York-based CDMO Kinentia Biosciences.…
SGD Pharma Broadens Glass Vial Portfolio With New Nasal and RTU Offerings
SGD Pharma is expanding its pharmaceutical glass packaging portfolio with new molded and tubular vial solutions aimed at drug developers working with high-value and increasingly…
CPHI Milan Brings Pharma Industry Together for Practical Sustainability Summit
Pharmaceutical companies, suppliers and sustainability specialists will gather in Milan at CPHI this week for a new industry forum aimed at moving sustainability discussions from…
Agilent Adds Boulder Lab to Expand Oligonucleotide Manufacturing Capabilities
Agilent Technologies is expanding its oligonucleotide manufacturing infrastructure with a new laboratory in Boulder, Colorado, aimed at advancing and scaling emerging production technologies for oligonucleotide…
Credence MedSystems Earns ISO 13485 Certification as it Expands Drug Delivery Manufacturing Readiness
Credence MedSystems has secured ISO 13485:2016 certification for its quality management system, a milestone the drug-delivery technology company says strengthens its position as a potential…
